HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

omalizumab (Xolair)

a recombinant humanised monoclonal antibody which specifically binds to the C epsilon3 domain of immunoglobulin (Ig) E, the site of high-affinity IgE receptor binding
Also Known As:
Xolair; Novartis Brand of Omalizumab
Networked: 892 relevant articles (247 outcomes, 239 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Maurer, Marcus: 17 articles (09/2015 - 09/2010)
2. Casale, Thomas B: 13 articles (09/2015 - 12/2003)
3. Yalcin, Arzu Didem: 12 articles (01/2015 - 01/2012)
4. Buhl, R: 12 articles (03/2014 - 08/2001)
5. Fox, H: 11 articles (07/2007 - 01/2001)
6. Saini, Sarbjit S: 10 articles (09/2015 - 08/2005)
7. Hamilton, Robert G: 9 articles (01/2014 - 08/2005)
8. Bousquet, J: 9 articles (05/2011 - 01/2001)
9. Blogg, M: 9 articles (06/2010 - 07/2004)
10. Rosén, Karin: 8 articles (09/2015 - 03/2013)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Urticaria (Hives)
3. Rhinitis
4. Seasonal Allergic Rhinitis (Hay Fever)
5. Atopic Dermatitis (Atopic Eczema)

Related Drugs and Biologics

1. anti-IgE
2. Immunoglobulin E (IgE)
3. Adrenal Cortex Hormones (Corticosteroids)
4. omalizumab (Xolair)
5. Histamine Antagonists (Antihistamines)
6. Steroids
7. Immunoglobulin G (IgG)
8. Immunoglobulins (Immunoglobulin)
9. Prednisolone (Predate)
10. Prednisone (Sone)

Related Therapies and Procedures

1. Immunotherapy
2. Aftercare (After-Treatment)
3. Retreatment
4. Stents
5. Drug Therapy (Chemotherapy)